Neurodevelopmental Disorders

Latest News

Insomnia and Alcohol Consumption Linked to ADHD Symptoms

By

Emily Pond

Among adults without a clinical diagnosis of ADHD, heavy alcohol use predicted more severe ADHD symptoms.

Psychiatric Disorders May Share Common Neurodevelopmental Cortical Thinning Patterns

By

Jessica Nye

The researchers concluded that the correlation between interregional cortical thinning during maturation and expression patterns of genes associated with multiple psychiatric disorders suggested a common molecular process.

Triple Reuptake Inhibitor Centanafadine Looks Promising for Adult ADHD

By

Brian Park, PharmD

Centanafadine is a serotonin-norepinephrine-dopamine reuptake inhibitor. The two, 6-week, multicenter, double-blind, placebo-controlled trials (Study 1 and Study 2) evaluated the efficacy and safety of centanafadine sustained-release tablets in approximately 900 adult patients with ADHD.

Stigmas Identified in Nurse Practitioners’ Attitudes Toward Managing Mental Health Conditions

By

Madeline Morr

Researchers conducted a cross-sectional study to assess nurse practitioners’ attitudes and beliefs regarding working with individuals with a mental health disorder.

Worsened ADHD Behaviors Reported for Children During COVID-19

For children with attention-deficit/hyperactivity disorder, parents reported worsened ADHD behaviors during the COVID-19 outbreak, with children’s and parents’ moods positively associated with behavior.

Discontinuing Medication Slightly Decreases Quality of Life in Youths with ADHD

By

Laurel Ranger

The investigators observed a statistically significant relapse rate among those discontinuing medication for ADHD, which remained significant in subgroup analyses of both age groups.

FDA to Review Manipulation-Resistant Stimulant Med for ADHD

By

Brian Park, PharmD

AR19 is an investigational immediate-release, amphetamine formulated to prevent the manipulation of the pellets in the capsules for nonmedical use.

Dasotraline Development for ADHD, Binge Eating Disorder Halted, NDAs Withdrawn

By

Brian Park, PharmD

n August 2018, the Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) stating the application required additional data to further assess the efficacy and tolerability of dasotraline.

Genetic Links Found Between Childhood Psychopathology and Adult Depression

By

Laurel Ranger

Researchers found strong evidence that polygenic scores for adult major depression, subjective wellbeing, neuroticism, insomnia, educational attainment, and BMI are associated with childhood ADHD symptoms, internalizing and social problems.

Study Supports Using WURS and ASRS Jointly to Assess Adult ADHD

By

Dibash Kumar Das, PhD

In this study, researchers sought to investigate the psychometric properties of the ASRS and WURS in a well-characterized sample of adult ADHD patients and population controls.